BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17118720)

  • 1. SELDI-TOF mass spectra: a view on sources of variation.
    Dijkstra M; Vonk RJ; Jansen RC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):12-23. PubMed ID: 17118720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
    Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Lucid Proteomics System for top-down biomarker research.
    Jourdain S; Bulman A; Dalmasso E
    Arch Physiol Biochem; 2010; 116(4-5):158-62. PubMed ID: 20507259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving feature detection and analysis of surface-enhanced laser desorption/ionization-time of flight mass spectra.
    Carlson SM; Najmi A; Whitin JC; Cohen HJ
    Proteomics; 2005 Jul; 5(11):2778-88. PubMed ID: 15986333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
    West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
    Leung SM; Pitts RL
    Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benchmarking currently available SELDI-TOF MS preprocessing techniques.
    Emanuele VA; Gurbaxani BM
    Proteomics; 2009 Apr; 9(7):1754-62. PubMed ID: 19294696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI TOF-MS) and ProteinChip technology in proteomics research.
    Seibert V; Wiesner A; Buschmann T; Meuer J
    Pathol Res Pract; 2004; 200(2):83-94. PubMed ID: 15237917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an on-target sample preparation system for matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in conjunction with normal-flow peptide high-performance liquid chromatography for peptide mass fingerprint analyses.
    McComb ME; Perlman DH; Huang H; Costello CE
    Rapid Commun Mass Spectrom; 2007; 21(1):44-58. PubMed ID: 17133622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proteomics technology for screening biomarkers of oligospermic candidates].
    Yang H; Zhang J; Zhang W; Long W; Zhang XB
    Zhonghua Nan Ke Xue; 2006 Jan; 12(1):39-42. PubMed ID: 16483157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-source decay causes artifacts in SELDI-TOF MS spectra.
    Ekblad L; Baldetorp B; Fernö M; Olsson H; Bratt C
    J Proteome Res; 2007 Apr; 6(4):1609-14. PubMed ID: 17373843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data.
    Park Y; Downing SR; Kim D; Hahn WC; Li C; Kantoff PW; Wei LJ
    Bioinformatics; 2007 Jun; 23(12):1451-8. PubMed ID: 17459967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic profiling using mass spectrometry--does normalising by total ion current potentially mask some biological differences?
    Cairns DA; Thompson D; Perkins DN; Stanley AJ; Selby PJ; Banks RE
    Proteomics; 2008 Jan; 8(1):21-7. PubMed ID: 18095358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving sample treatment for in-solution protein identification by peptide mass fingerprint using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Santos HM; Rial-Otero R; Fernandes L; Vale G; Rivas MG; Moura I; Capelo JL
    J Proteome Res; 2007 Sep; 6(9):3393-9. PubMed ID: 17683131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finding regions of significance in SELDI measurements for identifying protein biomarkers.
    Tan CS; Ploner A; Quandt A; Lehtiö J; Pawitan Y
    Bioinformatics; 2006 Jun; 22(12):1515-23. PubMed ID: 16567365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
    Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
    J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometric profiling - a diagnostic tool in fish?
    Provan F; Bjørnstad A; Pampanin DM; Lyng E; Fontanillas R; Andersen OK; Koppe W; Bamber S
    Mar Environ Res; 2006 Jul; 62 Suppl():S105-8. PubMed ID: 16764920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular biomarker discovery by SELDI-TOF mass spectrometry.
    Meilhac O; Delbosc S; Michel JB
    Methods Mol Biol; 2007; 357():331-41. PubMed ID: 17172699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.